Great Novel Therapeutics Biotech & Medicals (7427.TWO)
TWD 32.85
(-18.69%)
TWD 32.85
(-18.69%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 2.61 Million TWD | 19.13% |
| 2022 | 57.9 Million TWD | 57.33% |
| 2021 | 36.8 Million TWD | 23.15% |
| 2020 | 29.88 Million TWD | 0.0% |
| 2019 | - TWD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 32.72 Million TWD | 117.11% |
| 2024 Q2 | 32.69 Million TWD | -0.08% |
| 2023 Q3 | 15.07 Million TWD | -26.31% |
| 2023 FY | 68.97 Million TWD | 19.13% |
| 2023 Q1 | 20.45 Million TWD | 4.88% |
| 2023 Q4 | 15.07 Million TWD | 0.0% |
| 2023 Q2 | 20.45 Million TWD | 0.0% |
| 2022 Q3 | 19.5 Million TWD | 0.0% |
| 2022 FY | 57.9 Million TWD | 57.33% |
| 2022 Q4 | 19.5 Million TWD | 0.0% |
| 2021 FY | 36.8 Million TWD | 23.15% |
| 2020 FY | 29.88 Million TWD | 0.0% |
| 2019 FY | - TWD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | -694.833% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 127.67 Million TWD | 97.952% |
| Level Biotechnology Inc. | 151.99 Million TWD | 98.28% |
| Sagittarius Life Science Corp | 135.85 Million TWD | 98.075% |
| NeoCore Technology Co., Ltd. | 75.85 Million TWD | 96.553% |
| TaiMed Biologics Inc. | 225.23 Million TWD | 98.839% |
| GlycoNex Incorporation | 995 Thousand TWD | -162.814% |
| VBI | 32.55 Million TWD | 91.967% |
| GeneReach Biotechnology Corp. | 256.86 Million TWD | 98.982% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 194.18 Million TWD | 98.653% |
| SynCore Biotechnology Co.,Ltd | 46.02 Million TWD | 94.318% |
| Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | 97.819% |
| Visgeneer Inc. | 67.48 Million TWD | 96.125% |
| Mycenax Biotech Inc. | -375.19 Million TWD | 100.697% |
| Sunmax Biotechnology Co., Ltd. | 510.09 Million TWD | 99.487% |
| G&E Herbal Biotechnology Co., Ltd. | 63.9 Million TWD | 95.908% |
| Neith Corporation | 66.87 Million TWD | 96.09% |
| Medigen Vaccine Biologics Corporation | 1.44 Billion TWD | 99.819% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 29.35 Million TWD | 91.091% |
| Enimmune corporation | 220.1 Million TWD | 98.812% |
| TaiRx, Inc. | 217.13 Million TWD | 98.796% |
| CHO Pharma, Inc. | 268.99 Million TWD | 99.028% |
| EirGenix Inc. | 236.74 Million TWD | 98.895% |
| BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | 97.494% |
| Sunny Pharmtech Inc. | 357.62 Million TWD | 99.269% |
| Lin BioScience, Inc. | 1.09 Billion TWD | 99.762% |
| BioGend Therapeutics Co., Ltd. | 266.15 Million TWD | 99.018% |
| Feng Chi Biotech Corp. | 49.47 Million TWD | 94.714% |
| Bio Preventive Medicine Corp. | 1.08 Million TWD | -141.459% |
| Lukas Biomedical Inc. | 177.45 Million TWD | 98.526% |
| RBC Bioscience Corporation | 58.35 Million TWD | 95.519% |
| BiOptic Inc. | 108.69 Million TWD | 97.594% |
| BRIM Biotechnology, Inc. | 90 Thousand TWD | -2805.556% |
| Shine-On BioMedical Co.,Ltd. | 69.35 Million TWD | 96.229% |
| Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 99.594% |
| Advagene Biopharma Co., Ltd. | 93.33 Million TWD | 97.198% |
| NaviFUS Corp. | 11.82 Million TWD | 77.89% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 190.72 Million TWD | 98.629% |
| Sinew Pharma Inc. | 186.25 Million TWD | 98.596% |
| Andros Pharmaceuticals Co.,Ltd | 74.02 Million TWD | 96.467% |
| Greenyn Biotechnology Co., Ltd | 220.39 Million TWD | 98.814% |
| Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | 93.696% |
| AP Biosciences Inc | 32.25 Million TWD | 91.892% |
| Medigen Biotechnology Corp. | 1.85 Billion TWD | 99.859% |
| 3D Global Biotech Inc. | 5.27 Million TWD | 50.417% |
| Pharmosa Biopharm Inc. | 317.32 Million TWD | 99.176% |
| Intech Biopharm Corporation | -163.99 Million TWD | 101.595% |
| Oneness Biotech Co., Ltd. | 1.12 Billion TWD | 99.768% |
| Eusol Biotech Co.,Ltd. | 41.48 Million TWD | 93.696% |
| TWi Biotechnology, Inc. | 169.55 Million TWD | 98.458% |
| Ever Supreme Bio Technology Co., Ltd | 147.02 Million TWD | 98.221% |
| TCI GENE Inc. | 174.61 Million TWD | 98.502% |
| MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -14427.778% |
| Senhwa Biosciences, Inc. | 300.93 Million TWD | 99.131% |
| Taiwan Bio Therapeutics Co., Ltd | 290.95 Million TWD | 99.101% |
| NatureWise Biotech & Medicals Corporation | 83.94 Million TWD | 96.885% |
| PharmaEngine, Inc. | 441.78 Million TWD | 99.408% |
| Savior Lifetec Corporation | 223.36 Million TWD | 98.829% |
| TaiGen Biopharmaceuticals Holdings Limited | 258.77 Million TWD | 98.989% |
| OBI Pharma, Inc. | 2.01 Billion TWD | 99.87% |
| Meribank Biotech Co., Ltd | 138.87 Million TWD | 98.117% |
| Acepodia, Inc. | 452.56 Million TWD | 99.422% |
| Caliway Biopharmaceuticals Co., Ltd. | 540.93 Million TWD | 99.517% |